Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Mabwell Publishes the Phase III Study Results on Its Denosumab Biosimilar (MW032) in the journal JAMA Oncology
2024-02-21 22:00
Zylox-Tonbridge Receives Marketing Approvals for Multiple Products in the UAE
2024-02-21 16:16
Ono Enters into a Research Collaboration Agreement with InveniAI to Identify Novel Therapeutic Targets
2024-02-21 11:56
Hox Therapeutics and Vernalis announce a drug discovery collaboration in oncology
2024-02-20 22:30
Mabwell Receives IND Approval from FDA for Novel B7-H3 ADC 7MW3711
2024-02-20 22:00
FDA Grants Orphan Drug Designation to 9MW3011
2024-02-20 22:00
WuXi Advanced Therapies Receives FDA Approval to Manufacture Iovance's AMTAGVI™ (lifileucel) for Advanced Melanoma
2024-02-20 21:00
Kangpu Biopharmaceuticals to Present Preclinical Efficacy Data of KPG-818 in Crohn's Disease at the 19th Congress of ECCO (IND Application for Phase II in Progress)
2024-02-20 20:00
Concord Medical Announces Receipt of NYSE Non-Compliance Letter Regarding ADS Trading Price
2024-02-20 20:00
Neurophth Announces Completion of Patient Enrollment for Opvika® Phase I/II Clinical Trial in the U.S.
2024-02-19 19:30
Jacobio Announces China CDE Clearance for Phase III Clinical Trial of SHP2 Inhibitor Plus KRAS G12C Inhibitor
2024-02-18 20:50
China Medical University Hospital (CMUH) in Taiwan Upgrades Smart Healthcare with Gen AI
2024-02-17 21:30
New Study Demonstrates Predictive Value of Lunit SCOPE IO to Predict Outcomes of Immune Checkpoint Inhibitor Therapy Across Diverse Tumors - published in the JITC
2024-02-16 22:03
iNtRON, Development of PHAGERIA® Anti-Cancer Candidate with Enhanced Antimicrobial Activity by Robot Bacteriophage platform technology
2024-02-15 11:37
STARmed to Accelerate Global Market Entry of EUSRA and ELRA Products through Olympus
2024-02-14 22:00
Sky Labs' CART BP Becomes the World's First to Complete Comparative Studies with All Blood Pressure Measurement Methods
2024-02-14 21:00
YS Biopharma Announces Appointment of New Directors
2024-02-14 20:50
GC Biopharma Presents Updates on its LSD Treatments at the WORLDSymposium 2024
2024-02-14 16:33
PCA 500™-- the world's most efficient and versatile 12-lead ECG, receives FDA clearance for use in acute care
2024-02-14 00:30
Datasea Reports Second Quarter Fiscal Year 2024 Financial Results and Operations Update - Second Quarter Revenue is $11.3 Million Versus $0.1 Million in the Year-Ago Period
2024-02-13 22:35
1
39
40
41
42
43
431